COMPANY PROFILE

Zyngenia

Explore full profile

Biotherapeutics company focused on the development of the next-generation of antibody-derived drugs

Gaithersburg, United StatesFounded 2008Biotech & Life Sciences

Valuation $100–250M Last recorded · 2010

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Zyngenia

Zyngenia Inc. is a pioneering biotherapeutics company focused on the development of novel multi-specific antibody treatments for cancer. Established in 2009, Zyngenia operates within the life sciences and pharmaceutical sectors, targeting oncology as its primary market. The company serves a range of clients including healthcare providers, research institutions, and pharmaceutical companies. Zyngenia's business model revolves around the research, development, and commercialization of its proprietary antibody therapeutics. Revenue is generated through partnerships, licensing agreements, and direct sales of its biotherapeutic products. The company has demonstrated preclinical efficacy in its treatments and continues to expand its board with leading industry experts to drive innovation and growth.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2008
Headquarters: Gaithersburg, United States
Open positions: None listed
Dealroom signal: 21.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2010	$25M	$100M	NEA	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Zyngenia website traffic

Latest recorded traffic for Zyngenia is 300 monthly website visits, down 95.3% over the last three months.

Latest monthly visits300 3-month web change-95.3%

Monthly website visitsMay 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
INInnoVeinInnoVein is revolutionizing vein care with an implantable valve	San Carlos, United States	Closed	2	$11M	$10M
GBGOGO BANDA medical devices company pioneering the use of biometric data from wearables using AI/ML predictive analytics to manage chronic health conditions	Ashland, United States	Operational
CECellSineProvides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher	Etterbeek, Belgium	Operational
IBInterAx BiotechDelivering High-Quality Drug Candidates for GPCR Targets	Villigen, Switzerland	Operational
SYSynyiThe leading medical artificial intelligence company focusing on medical data governance, mining, and application	Pudong, China	Operational
OUOutsenseOutSense has developed a novel technology capable of accurately analyzing and diagnosing human waste from within a standard toilet bowl	Or Yehuda, Israel	Operational
MTMedivie TherapeuticThe world's leading manufacturer of customized dental protectors	Tel Aviv-Yafo, Israel	Operational
SOSDS OpticFirst ever European based cutting-edge medical DeepTech connecting molecular biology with novel photonics technologies, chemistry & biomedical engineering	Lublin, Poland	Operational